Publication Name	World Journal of Gastroenterology
Manuscript ID	5849
Country	China

Received	2013-09-28 15:46
Peer-Review Started	2013-09-29 12:23
First Decision by Editorial Office Director
Return for Revision	2013-10-23 11:13
Revised	2013-11-14 10:43
Publication Fee Transferred
Second Decision by Editor	2013-12-13 14:01
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2013-12-13 14:55
Articles in Press
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-01-10 14:53
Publish the Manuscript Online	2014-01-26 20:08

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Autobiography
Article Title	Phase I  study of postoperative radiotherapy combined with capecitabine for gastric cancer
Manuscript Source	Invited Manuscript
All Author List	Xin Wang, Jing Jin, Ye-Xiong Li, Hua Ren, Hui Fang, Shu-Lian Wang, Yue-Ping Liu, Wei-Hu Wang, Zi-Hao Yu, Yong-Wen Song and Xin-Fan Liu
Funding Agency and Grant Number	Funding Agency Grant Number Beijing Hope Run Special Fund LC2007A03
Corresponding Author	Jing Jin, MD, Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Panjiayuan Nanli 17, Chaoyang District, Beijing 100021, China. jingjin1025@163.com
Key Words	Radiotherapy; Capecitabine; Gastric cancer; Maximum tolerated dose; Dose-limiting toxicity
Core Tip	Postoperative chemoradiotherapy is a good option for patients with locally advanced, gastric cancer who have undergone R0 and D0-1 lymphadenectomy. To avoid acute side effects and make the drug safer, a combination of the use of advanced techniques such as intensity modulated radiotherapy and mature chemotherapy regimens with capecitabine is highly recommended, especially in China which accounts for 40% of the world’s gastric cancer patients. The aim of this single-institution, phase I, clinical trial was to assess the feasibility and toxicity of a postoperative regimen involving dose escalation of capecitabine combined with IMRT for locally advanced gastric cancer.
Publish Date	2014-01-26 20:08
Citation	Wang X, Jin J, Li YX, Ren H, Fang H, Wang SL, Liu YP, Wang WH, Yu ZH, Song YW, Liu XF. Phase Ⅰ study of postoperative radiotherapy combined with capecitabine for gastric cancer. World J Gastroenterol 2014; 20(4): 1067-1073
URL	http://www.wjgnet.com/1007-9327/full/v20/i4/1067.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i4.1067

Full Article (PDF)	WJG-20-1067.pdf
Full Article (Word)	WJG-20-1067.doc
Manuscript File	5849-Review.doc
Answering Reviewers	5849-Answering reviewers.pdf
Copyright License Agreement	5849-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	5849-Language certificate.pdf
Peer-review Report	5849-Peer reviews.pdf
Scientific Editor Work List	5849-Scientific editor work list.doc